• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anticoagulation for Nonvalvular Atrial Fibrillation: Influence of Epidemiologic Trends and Clinical Practice Patterns on Risk Stratification and Net Clinical Benefit.

作者信息

Asinger Richard W, Shroff Gautam R, Simegn Mengistu A, Herzog Charles A

机构信息

From the Division of Cardiology, Department of Medicine, Hennepin County Medical Center and University of Minnesota, Minneapolis (R.W.A., G.R.S., M.A.S., C.A.H.); and Chronic Disease Research Group, Minneapolis Medical Research Foundation, MN (C.A.H.).

出版信息

Circ Cardiovasc Qual Outcomes. 2017 Sep;10(9). doi: 10.1161/CIRCOUTCOMES.117.003669.

DOI:10.1161/CIRCOUTCOMES.117.003669
PMID:28893833
Abstract
摘要

相似文献

1
Anticoagulation for Nonvalvular Atrial Fibrillation: Influence of Epidemiologic Trends and Clinical Practice Patterns on Risk Stratification and Net Clinical Benefit.非瓣膜性心房颤动的抗凝治疗：流行病学趋势和临床实践模式对风险分层及净临床获益的影响
Circ Cardiovasc Qual Outcomes. 2017 Sep;10(9). doi: 10.1161/CIRCOUTCOMES.117.003669.
2
Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.直接口服抗凝剂和华法林治疗心房颤动患者的处方模式和结局：真实世界分析。
J Cardiovasc Pharmacol Ther. 2019 Sep;24(5):428-434. doi: 10.1177/1074248419841634. Epub 2019 Apr 29.
3
Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter study.泰国非瓣膜性心房颤动患者的风险特征及抗血栓药物使用模式：一项多中心研究。
BMC Cardiovasc Disord. 2018 Aug 25;18(1):174. doi: 10.1186/s12872-018-0911-4.
4
Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.直接口服抗凝剂与华法林用于非瓣膜性心房颤动的使用和比较效果的时间趋势：一项加拿大基于人群的研究。
J Am Heart Assoc. 2017 Oct 28;6(11):e007129. doi: 10.1161/JAHA.117.007129.
5
Underuse of Oral Anticoagulants for Nonvalvular Atrial Fibrillation: Past, Present, and Future.非瓣膜性心房颤动口服抗凝剂的使用不足：过去、现在与未来
Tex Heart Inst J. 2016 Aug 1;43(4):287-90. doi: 10.14503/THIJ-16-5785. eCollection 2016 Aug.
6
Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation.老年房颤患者抗凝处方的相关因素
Eur J Prev Cardiol. 2019 Apr;26(6):660-663. doi: 10.1177/2047487318795237. Epub 2018 Aug 28.
7
Underuse of Vitamin K Antagonist and Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A Contemporary Review.维生素 K 拮抗剂和直接口服抗凝剂在预防心房颤动患者中风中的应用不足：当代综述。
Clin Pharmacol Ther. 2018 Aug;104(2):301-310. doi: 10.1002/cpt.1024. Epub 2018 Feb 13.
8
Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: A population-based study.以色列诊断为心房颤动后 3 个月内口服抗凝治疗的使用情况：一项基于人群的研究。
J Cardiovasc Electrophysiol. 2020 Jun;31(6):1356-1363. doi: 10.1111/jce.14452. Epub 2020 Apr 1.
9
Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use.直接口服抗凝剂使用的时间变化与其有效性和安全性的关系
Circ Cardiovasc Qual Outcomes. 2020 Mar;13(3):e005894. doi: 10.1161/CIRCOUTCOMES.119.005894. Epub 2020 Mar 12.
10
Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF).中国心房颤动患者的卒中风险状况、抗凝治疗和生活质量：中国心房颤动注册研究（CRAF）。
Cardiovasc Ther. 2019 Mar 21;2019:7372129. doi: 10.1155/2019/7372129. eCollection 2019.

引用本文的文献

1
Clinical Impact of Switching or Continuation of Apixaban or Rivaroxaban among Patients with Non-Valvular Atrial Fibrillation.非瓣膜性心房颤动患者中阿哌沙班或利伐沙班换药或续用的临床影响
J Clin Med. 2024 Feb 14;13(4):1073. doi: 10.3390/jcm13041073.
2
Statin Use and Stroke Rate in Older Adults With Atrial Fibrillation: A Population-Based Cohort Study.他汀类药物在老年心房颤动患者中的应用与卒中发生率：一项基于人群的队列研究。
J Am Heart Assoc. 2023 Jun 20;12(12):e028381. doi: 10.1161/JAHA.122.028381. Epub 2023 Jun 15.
3
Ischemic stroke risk estimation in patients without oral anticoagulation: an observational cohort study based on secondary data from Germany.
未接受口服抗凝治疗患者的缺血性脑卒中风险评估：基于德国二级数据的观察性队列研究。
BMC Cardiovasc Disord. 2019 Apr 23;19(1):94. doi: 10.1186/s12872-019-1074-7.
4
Importance of Considering Competing Risks in Time-to-Event Analyses: Application to Stroke Risk in a Retrospective Cohort Study of Elderly Patients With Atrial Fibrillation.在事件发生时间分析中考虑竞争风险的重要性：在老年房颤患者回顾性队列研究中对中风风险的应用
Circ Cardiovasc Qual Outcomes. 2018 Jul;11(7):e004580. doi: 10.1161/CIRCOUTCOMES.118.004580.